Stay up to date with the latest PathAI updates, new features, and improvements. Here's what changed in 2026.
In February 2026, Labcorp expanded its collaboration with PathAI to deploy the FDA
In February 2026, PathAI expanded the AISight Clinical Trials Platform with AIM
PathAI continued highlighting the 2025 FDA clearance of AISight Dx for primary diagnosis, including a Predetermined Change Control Plan intended to support specified future updates without additional 510(k) submissions. PathAI continued expanding clinical trial and biopharma positioning around AIM
MASH AI Assist, which the company says received FDA qualification for MASH clinical trials in late
PathAI is actively developing new features. Check back regularly or follow their official channels for the latest updates.
Follow their release notes for instant updates
Test the latest updates in your workflow
Help shape future development with your input
Try out all the new features and improvements that make PathAI even more powerful.
Changelog last updated March 2026